Raymond James & Associates Azenta, Inc. Transaction History

Raymond James & Associates

$161 Billion
Q3 2024

A detailed history of Raymond James & Associates transactions in Azenta, Inc. stock. As of the latest transaction made, Raymond James & Associates holds 77,105 shares of AZTA stock, worth $3.22 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

77,105

Previous 110,948 30.5%

Holding current value

$3.22 Million

Previous $5.84 Million 36.04%

% of portfolio

0.0%

Previous 0.0%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 18, 2024	SELL	$45.84 - $62.29 $1.55 Million - $2.11 Million	-33,843 Reduced 30.5%	77,105 $3.73 Million
Q2 2024 Jul 19, 2024	BUY	$50.27 - $59.04 $29,860 - $35,069	594 Added 0.54%	110,948 $5.84 Million
Q1 2024 Apr 22, 2024	BUY	$57.82 - $67.51 $822,662 - $960,532	14,228 Added 14.8%	110,354 $6.65 Million
Q4 2023 Jan 16, 2024	BUY	$44.02 - $66.3 $12,545 - $18,895	285 Added 0.3%	96,126 $6.26 Million
Q3 2023 Oct 24, 2023	SELL	$44.08 - $57.76 $132,636 - $173,799	-3,009 Reduced 3.04%	95,841 $4.81 Million
Q2 2023 Jul 25, 2023	SELL	$36.45 - $46.68 $27,009 - $34,589	-741 Reduced 0.74%	98,850 $4.61 Million
Q1 2023 Apr 14, 2023	BUY	$39.51 - $61.95 $1.34 Million - $2.11 Million	34,005 Added 51.85%	99,591 $4.44 Million
Q4 2022 Feb 08, 2023	BUY	$38.6 - $62.07 $273,056 - $439,083	7,074 Added 12.09%	65,586 $3.82 Million
Q3 2022 Oct 25, 2022	BUY	$42.86 - $77.02 $676,202 - $1.22 Million	15,777 Added 36.92%	58,512 $2.51 Million
Q2 2022 Aug 12, 2022	BUY	$64.69 - $85.07 $21,994 - $28,923	340 Added 0.8%	42,735 $3.08 Million
Q1 2022 May 11, 2022	SELL	$76.3 - $103.81 $2.24 Million - $3.05 Million	-29,418 Reduced 40.96%	42,395 $3.51 Million
Q4 2021 Feb 08, 2022	BUY	$92.98 - $124.15 $88,888 - $118,687	956 Added 1.35%	71,813 $7.41 Million
Q3 2021 Nov 02, 2021	BUY	$77.49 - $109.17 $1.75 Million - $2.47 Million	22,618 Added 46.89%	70,857 $7.25 Million
Q2 2021 Aug 11, 2021	BUY	$86.59 - $107.47 $261,328 - $324,344	3,018 Added 6.67%	48,239 $4.6 Million
Q1 2021 May 14, 2021	BUY	$66.32 - $90.93 $1.87 Million - $2.56 Million	28,123 Added 164.48%	45,221 $3.69 Million
Q4 2020 Feb 12, 2021	BUY	$46.7 - $75.22 $23,957 - $38,587	513 Added 3.09%	17,098 $1.16 Million
Q3 2020 Nov 04, 2020	SELL	$42.77 - $56.69 $1.14 Million - $1.51 Million	-26,688 Reduced 61.67%	16,585 $767,000
Q2 2020 Jul 28, 2020	SELL	$26.54 - $44.24 $284,588 - $474,385	-10,723 Reduced 19.86%	43,273 $1.91 Million
Q1 2020 Apr 21, 2020	BUY	$22.69 - $44.14 $766,332 - $1.49 Million	33,774 Added 167.02%	53,996 $1.65 Million
Q4 2019 Feb 12, 2020	SELL	$35.49 - $48.05 $21,116 - $28,589	-595 Reduced 2.86%	20,222 $848,000
Q3 2019 Nov 07, 2019	SELL	$30.18 - $41.75 $2,776 - $3,841	-92 Reduced 0.44%	20,817 $771,000
Q2 2019 Aug 06, 2019	SELL	$29.53 - $41.1 $59,562 - $82,898	-2,017 Reduced 8.8%	20,909 $810,000
Q1 2019 May 06, 2019	BUY	$24.38 - $33.75 $43,055 - $59,602	1,766 Added 8.35%	22,926 $672,000
Q4 2018 Feb 11, 2019	SELL	$23.22 - $35.29 $1.03 Million - $1.56 Million	-44,193 Reduced 67.62%	21,160 $554,000
Q3 2018 Nov 14, 2018	BUY	$28.71 - $39.6 $1.06 Million - $1.46 Million	36,770 Added 128.64%	65,353 $2.29 Million
Q2 2018 Aug 14, 2018	BUY	$24.88 - $36.36 $377,429 - $551,581	15,170 Added 113.1%	28,583 $932,000
Q1 2018 May 14, 2018	BUY	$23.3 - $30.15 $312,522 - $404,401	13,413 New	13,413 $363,000
Q4 2017 Feb 14, 2018	SELL	$22.54 - $34.39 $915,191 - $1.4 Million	-40,603 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$22.6 - $30.36 $438,666 - $589,287	19,410 Added 91.59%	40,603 $1.23 Million
Q2 2017 Aug 14, 2017	BUY	N/A	21,193	21,193 $460,000

Others Institutions Holding AZTA

# of Institutions

338

Shares Held

53.7M

Call Options Held

260K

Put Options Held

238K

View Full List

About Azenta, Inc.

Ticker AZTA
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 75,020,400
Market Cap $3.14B
Description
Azenta, Inc. provides life science sample exploration and management solutions for the life sciences market in North America, Europe, China, the Asia Pacific, and internationally. The company operates through two reportable segments, Life Sciences Products and Life Sciences Services. The Life Sciences Products segment offers automated cold sampl...

More about AZTA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.

Account

Raymond James & Associates Azenta, Inc. Transaction History